Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain
- PMID: 7248786
- DOI: 10.1016/0006-8993(81)90148-7
Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain
Abstract
The postmortem stability of alpha-bungarotoxin binding sites was examined in the brains of mice handled under conditions designed to simulate the handling of human autopsy material. No significant changes in the concentration of binding sites were evident up to 24 h after death. No correlation between the number of binding sites and the delay period between death and autopsy was found in studies of frontal cortex or mid-temporal gyrus from normal humans or cases of dementia of the Alzheimer type. Samples of mid-temporal gyrus from demented patients show a significant reduction in the number of binding sites.
Similar articles
-
Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.Brain Res. 1983 May 16;267(2):271-80. doi: 10.1016/0006-8993(83)90879-x. Brain Res. 1983. PMID: 6871676
-
Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.J Neurosci Res. 1990 Nov;27(3):349-59. doi: 10.1002/jnr.490270314. J Neurosci Res. 1990. PMID: 2097379
-
Quantitative autoradiographic localization of [125I]alpha-bungarotoxin binding sites in the honeybee brain.Brain Res. 1990 Nov 26;534(1-2):332-5. doi: 10.1016/0006-8993(90)90152-2. Brain Res. 1990. PMID: 2073597
-
alpha-Bungarotoxin binding sites in the CNS.Life Sci. 1979 Mar 5;24(10):859-72. doi: 10.1016/0024-3205(79)90335-7. Life Sci. 1979. PMID: 376997 Review. No abstract available.
-
The cholinergic system in Alzheimer disease.Prog Brain Res. 1990;84:321-32. doi: 10.1016/s0079-6123(08)60916-4. Prog Brain Res. 1990. PMID: 2267306 Review. No abstract available.
Cited by
-
Brain imaging of nicotinic receptors in Alzheimer's disease.Int J Alzheimers Dis. 2010 Dec 28;2010:548913. doi: 10.4061/2010/548913. Int J Alzheimers Dis. 2010. PMID: 21253523 Free PMC article.
-
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.J Neurol Neurosurg Psychiatry. 1987 Jun;50(6):806-9. doi: 10.1136/jnnp.50.6.806. J Neurol Neurosurg Psychiatry. 1987. PMID: 2956364 Free PMC article.
-
[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.Nucl Med Biol. 2015 May;42(5):488-493. doi: 10.1016/j.nucmedbio.2014.12.008. Epub 2014 Dec 20. Nucl Med Biol. 2015. PMID: 25687449 Free PMC article.
-
Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.CNS Drugs. 2002;16(7):485-500. doi: 10.2165/00023210-200216070-00005. CNS Drugs. 2002. PMID: 12056923
-
Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.Neurochem Res. 1989 Aug;14(8):745-50. doi: 10.1007/BF00964952. Neurochem Res. 1989. PMID: 2812250
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources